Clopidogrel: a review of its use in the prevention of thrombosis (Q28220732)

https://api.crossref.org/works/10.2165%2F00003495-200767040-00013

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00013

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00013

A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00013

Pharmacokinetic profile of 14C-labeled clopidogrel

21 January 2018

1 reference

12 December 2020

Clopidogrel resistance: myth or reality?

1 reference

12 December 2020

Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.

1 reference

12 December 2020

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial

1 reference

12 December 2020

Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation

1 reference

12 December 2020

Clinical policy: critical issues in the evaluation and management of adult patients with non-ST-segment elevation acute coronary syndromes

1 reference

12 December 2020

Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents

1 reference

12 December 2020

Prolonged heparin administration during clopidogrel treatment in healthy subjects

1 reference

12 December 2020

Long-term versus short-term clopidogrel therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial)

1 reference

12 December 2020

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

12 December 2020

Clopidogrel bisulfate: in ST-segment elevation myocardial infarction

1 reference

12 December 2020

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin

1 reference

12 December 2020

Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation

1 reference

12 December 2020

The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study

1 reference

12 December 2020

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke...

1 reference

12 December 2020

A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention

1 reference

12 December 2020

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

1 reference

12 December 2020

Effect of clopidogrel on bleeding after coronary artery bypass surgery

1 reference

12 December 2020

Long-term activity of clopidogrel: a three-month appraisal in healthy volunteers

1 reference

12 December 2020

Clopidogrel does not affect the pharmacokinetics of theophylline

1 reference

12 December 2020

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents

1 reference

12 December 2020

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy

1 reference

12 December 2020

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

12 December 2020

Using clopidogrel in non-ST-segment elevation acute coronary syndrome patients: a cost-utility analysis in Spain.

1 reference

12 December 2020

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

1 reference

12 December 2020

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease

1 reference

12 December 2020

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

The role of the platelet in the pathogenesis of atherothrombosis

1 reference

12 December 2020

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease

1 reference

12 December 2020

Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis

1 reference

12 December 2020

A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy

1 reference

12 December 2020

Aspirin and clopidogrel resistance: consideration and management

1 reference

12 December 2020

Clopidogrel: a review of its use in the prevention of atherothrombosis

1 reference

12 December 2020

P2y(12), a new platelet ADP receptor, target of clopidogrel

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

12 December 2020

Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention

1 reference

12 December 2020

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement

1 reference

12 December 2020

Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome

1 reference

12 December 2020

Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma?

1 reference

12 December 2020

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

1 reference

12 December 2020

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation

1 reference

12 December 2020

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423].

1 reference

12 December 2020

Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested

1 reference

12 December 2020

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation

1 reference

12 December 2020

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

1 reference

12 December 2020

What is the optimal timing of clopidogrel in acute coronary syndromes?

1 reference

12 December 2020

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

1 reference

12 December 2020

In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?

1 reference

12 December 2020

Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry

1 reference

12 December 2020

Changing health environment: the challenge to demonstrate cost-effectiveness of new compounds

1 reference

12 December 2020

Identification and biological activity of the active metabolite of clopidogrel

1 reference

12 December 2020

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy

1 reference

12 December 2020

Aspirin and clopidogrel resistance: an emerging clinical entity

1 reference

12 December 2020

Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial

1 reference

12 December 2020

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization

1 reference

12 December 2020

Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome

1 reference

12 December 2020

Clopidogrel-statin interaction: a mountain or a mole hill?

1 reference

12 December 2020

Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?

1 reference

12 December 2020

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Pharmacokinetics of clopidogrel

1 reference

12 December 2020

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

12 December 2020

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

12 December 2020

Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents

1 reference

12 December 2020

1 reference

12 December 2020

The charisma of subgroups and the subgroups of CHARISMA

1 reference

12 December 2020

Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation

1 reference

12 December 2020

Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A

1 reference

12 December 2020

Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery

1 reference

12 December 2020

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

12 December 2020

Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.

1 reference

12 December 2020

1 reference

12 December 2020

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

1 reference

12 December 2020

Clopidogrel and thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study

1 reference

12 December 2020

Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes

1 reference

12 December 2020

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days

1 reference

12 December 2020

Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge

1 reference

12 December 2020

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

1 reference

12 December 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

12 December 2020

Clopidogrel bioavailability: absence of influence of food or antacids.

1 reference

12 December 2020

Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease

1 reference

12 December 2020

Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination

1 reference

12 December 2020

Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation

1 reference

12 December 2020

Resistance to clopidogrel: a review of the evidence

1 reference

12 December 2020

Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial)

1 reference

12 December 2020

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

1 reference

12 December 2020

Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis

1 reference

12 December 2020

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

1 reference

12 December 2020

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)

1 reference

12 December 2020

Comparison of cilostazol and clopidogrel after successful coronary stenting

1 reference

12 December 2020

Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation

1 reference

12 December 2020

Clopidogrel: potential in the prevention of cardiovascular events in patients with acute coronary syndromes

1 reference

12 December 2020

Clopidogrel Activities in Patients with Renal Function Impairment

1 reference

12 December 2020

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

1 reference

12 December 2020

Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?

1 reference

12 December 2020

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

12 December 2020

Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention

1 reference

12 December 2020

1 reference

12 December 2020

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

1 reference

12 December 2020

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

1 reference

12 December 2020

Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects

1 reference

12 December 2020

Early and late effects of clopidogrel in patients with acute coronary syndromes

1 reference

12 December 2020

Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting

1 reference

12 December 2020

Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice

1 reference

12 December 2020

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

12 December 2020

The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden

1 reference

12 December 2020

Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome

1 reference

12 December 2020

Clopidogrel and drug metabolism: absence of effect on hepatic enzymes in healthy volunteers

1 reference

12 December 2020

Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention

1 reference

12 December 2020

Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?

1 reference

12 December 2020

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

1 reference

12 December 2020

Cirrhosis does not affect the pharmacokinetics and pharmacodynamics of clopidogrel

1 reference

12 December 2020

Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?

1 reference

12 December 2020

A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial

1 reference

12 December 2020

Short-and long-term cost-effectiveness analysis of adding clopidogrel to standard therapy in acute coronary syndrome patients in Spain

1 reference

12 December 2020

Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment

1 reference

12 December 2020

Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population

1 reference

12 December 2020

Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS

1 reference

12 December 2020

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

1 reference

12 December 2020

Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

1 reference

12 December 2020

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

12 December 2020

Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting

1 reference

12 December 2020

Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting

1 reference

12 December 2020

Clopidogrel resistance: a new chapter in a fast-moving story

1 reference

12 December 2020

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

1 reference

12 December 2020

Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angiop

1 reference

12 December 2020

Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events

1 reference

12 December 2020

The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A

1 reference

12 December 2020

Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Ef

1 reference

12 December 2020

Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies

1 reference

12 December 2020

Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

12 December 2020

Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK

1 reference

12 December 2020

A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent

1 reference

12 December 2020

Clopidogrel, a novel antiplatelet agent, and digoxin: absence of pharmacodynamic and pharmacokinetic interaction

1 reference

12 December 2020

What is the price of life and why doesn't it increase at the rate of inflation?

1 reference

12 December 2020

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

12 December 2020

Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack

1 reference

12 December 2020

Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention

1 reference

12 December 2020

Is clopidogrel cardiovascular medicine's double-edged sword?

1 reference

12 December 2020

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th

1 reference

12 December 2020

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial

1 reference

12 December 2020

Clopidogrel versus ticlopidine after intracoronary stent placement

1 reference

12 December 2020

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

1 reference

12 December 2020

Variability in platelet responsiveness to clopidogrel among 544 individuals.

1 reference

12 December 2020

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention

1 reference

12 December 2020

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

1 reference

12 December 2020

A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK

1 reference

12 December 2020

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

1 reference

12 December 2020